Warrants Finder
Your selection:
427 Results
| FE1AXS | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 35.464% | 0.196 | -0.068 | 8.845 | 12/18/2026 | 0.100 | Société Générale | ||
| VJ121U |  | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 39.046% | 0.254 | -0.080 | 6.999 | 01/15/2027 | 0.100 | Vontobel | |
| VJ58F4 | | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 36.933% | 0.208 | -0.073 | 8.368 | 12/18/2026 | 0.100 | Vontobel | |
| VY41Y2 | | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600.000 | call | Vertex Pharmaceuticals Inc. | - | 38.693% | 0.361 | -0.071 | 4.831 | 06/17/2027 | 0.100 | Vontobel | |
| JY2HTR | Vertex Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620.000 | call | Vertex Pharmaceuticals Inc. | - | 41.361% | 0.235 | -0.080 | 6.810 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY32H7 | Vertex Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640.000 | call | Vertex Pharmaceuticals Inc. | - | 41.347% | 0.202 | -0.073 | 7.090 | 01/15/2027 | 0.100 | JP Morgan | ||
| GU1HQA | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 52.345% | 0.081 | -0.078 | 11.551 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GW31A1 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 35.706% | 0.261 | -0.056 | 5.724 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW31A0 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 38.637% | 0.167 | -0.061 | 7.880 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW31BQ | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 37.508% | 0.212 | -0.060 | 6.668 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW8VG4 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 38.377% | 0.378 | -0.057 | 3.902 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW97T7 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 65.074% | 0.053 | -0.088 | 13.839 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| MK35A2 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 43.667% | 0.175 | -0.008 | 7.554 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MR3C34 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 41.769% | 0.247 | -0.007 | 5.834 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MR3C33 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 39.835% | 0.293 | -0.007 | 5.051 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MR3C35 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Vertex Pharmaceuticals Inc. | - | 41.760% | 0.391 | -0.006 | 3.702 | 12/17/2027 | 0.010 | Morgan Stanley | |
| JY27MK | Vertex Pharmaceuticals Inc./OS/Call [660]/JPMD | - | - | 660.000 | call | Vertex Pharmaceuticals Inc. | - | 42.011% | 0.179 | -0.068 | 7.202 | 01/15/2027 | 0.100 | JP Morgan | ||
| GJ9P7M | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 43.996% | 0.116 | -0.057 | 8.189 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GJ9U7U | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 42.175% | 0.131 | -0.055 | 7.682 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GV70J9 | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 58.449% | 0.061 | -0.068 | 10.946 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV8H5W | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 36.567% | 0.200 | -0.049 | 6.025 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW01DP | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 38.182% | 0.318 | -0.052 | 4.150 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW1W63 | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 38.847% | 0.159 | -0.051 | 6.932 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW85MX | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 49.389% | 0.070 | -0.055 | 10.390 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| GW937Q | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 77.192% | 0.046 | -0.091 | 12.046 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| MK129T | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 47.190% | 0.139 | -0.007 | 7.422 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM0CJ2 | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 40.729% | 0.236 | -0.006 | 5.272 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MN3THD | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 68.377% | 0.099 | -0.012 | 8.728 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN3THE | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 41.833% | 0.336 | -0.006 | 3.893 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MR3C36 | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700.000 | call | Vertex Pharmaceuticals Inc. | - | 43.467% | 0.196 | -0.006 | 5.989 | 03/19/2027 | 0.010 | Morgan Stanley | |
| GW315E | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | 38.891% | 0.114 | -0.040 | 7.401 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW315D | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | 37.650% | 0.160 | -0.043 | 6.196 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW316C | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | 44.078% | 0.100 | -0.047 | 7.797 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW3NCK | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | 38.611% | 0.271 | -0.048 | 4.311 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GN01XC | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | 86.408% | 0.040 | -0.089 | 11.090 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| GN0T56 | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750.000 | call | Vertex Pharmaceuticals Inc. | - | - | - | - | - | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV0M67 | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 48.896% | 0.071 | -0.043 | 8.150 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GV0M6N | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 46.806% | 0.083 | -0.043 | 7.640 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GV9FAY | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 39.041% | 0.132 | -0.039 | 6.249 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GV9FBX | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 72.794% | 0.049 | -0.070 | 9.257 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GW03TU | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 39.413% | 0.235 | -0.045 | 4.404 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW1W5T | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 43.270% | 0.107 | -0.042 | 6.837 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW90EY | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 60.694% | 0.054 | -0.054 | 8.978 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| GW981Z | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 94.875% | 0.035 | -0.085 | 10.370 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| MK67TE | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 55.676% | 0.107 | -0.007 | 6.764 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MR3C39 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 47.974% | 0.140 | -0.006 | 5.938 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MR3C37 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 43.850% | 0.171 | -0.005 | 5.353 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MR3C38 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800.000 | call | Vertex Pharmaceuticals Inc. | - | 43.120% | 0.257 | -0.005 | 4.116 | 12/17/2027 | 0.010 | Morgan Stanley | |
| GW9A8R | Vertex Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850.000 | call | Vertex Pharmaceuticals Inc. | - | 40.814% | 0.112 | -0.036 | 6.210 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW9A8Y | Vertex Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850.000 | call | Vertex Pharmaceuticals Inc. | - | 44.865% | 0.088 | -0.037 | 6.866 | 03/19/2027 | 0.100 | Goldman Sachs |